about
Sarcoplasmic reticulum Ca2+ load in human heart failureFunctional relevance of the stretch-dependent slow force response in failing human myocardiumEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyMechanistic insight into the functional and toxic effects of Strophanthidin in the failing human myocardium[Assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy].Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).Na(+)-Ca(2+) exchanger overexpression predisposes to reactive oxygen species-induced injury.Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care.Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) studyDeveloping therapies for heart failure with preserved ejection fraction: current state and future directionsNatriuretic peptides in the detection of preclinical diastolic or systolic dysfunction.Left atrial strain predicts recurrence of atrial arrhythmias after catheter ablation of persistent atrial fibrillation.Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytesExpression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure.Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitorsSerum and glucocorticoid inducible kinases in the regulation of the cardiac sodium channel SCN5A.Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common databaseThe novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributHeart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribRandomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.Angiotensin II and myosin light-chain phosphorylation contribute to the stretch-induced slow force response in human atrial myocardiumCalcium cycling in congestive heart failure.[Na+]i handling in the failing human heart.ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1.Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophyNormal range and usefulness of right ventricular systolic strain to detect subtle right ventricular systolic abnormalities in patients with heart failure: a multicentre study.Natriuretic peptides for the detection of paroxysmal atrial fibrillation.Circulating dopamine and C-peptide levels in fasting nondiabetic hypertensive patients: the Graz Endocrine Causes of Hypertension studyPostprocedural radial artery occlusion rate using a sheathless guiding catheter for left ventricular endomyocardial biopsy performed by transradial approach.Fatty metaplasia quantification and impact on regional myocardial function as assessed by advanced cardiac MR imaging.Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial
P50
Q24336414-C0A41F32-9D1C-4FFA-A709-F44002A78266Q24337669-0E2756EE-1C1F-4D0F-8AA7-FFF4AD1746BCQ26796261-5A9ABA8B-A615-470A-B6B6-87BE7E94407EQ28254443-595DC791-4C1D-4A29-8C5A-32F9F52E0C9BQ30249032-5EB29472-B800-4C69-B449-AEF0BCA3DF5FQ30663685-C2549957-53D3-45F2-BB30-BA70E62B538FQ33162947-7EC276CD-856C-4FE5-BF33-D8E1466AA220Q33164685-F4D5D51F-0CB9-4B38-B6B1-B55F7D1DA808Q33194970-F4040D23-3FEC-4F96-8C92-CC9F46216285Q33321054-95619634-EBA2-46D6-BE60-AF95565F9FCAQ33562554-D4EAB4F2-76B0-4BEE-A75A-1F4B121C5E58Q33589713-59893D23-B2D3-4B4E-AE53-3334BBCC8382Q33639223-3184A373-37C9-4E62-8E69-609E96F828C5Q33743581-94C76BAF-6F94-4B66-9341-99383C30D928Q33801860-B3D24718-0D28-4999-912A-00502D241437Q34038333-BA6E2BA2-4EC8-4D19-964E-94FDE6963726Q34096941-AF31C409-7098-433A-A21A-72D0B56A3003Q34143216-67A785CD-8837-4DA8-B087-A097A8A1D048Q34144328-FC4CE87F-2AC7-4AC1-85C0-5ACE0E2EB15CQ34162294-3A986AE1-6CD4-4637-A427-0654BE5C8BEEQ34178582-D464130B-2BA5-44CE-8BFD-963342D3D0B2Q34185321-A6041AC9-4E7B-4F51-973A-7549DA6570AFQ34340734-6F4046B2-FE54-49DD-9B7B-15FFDF4274ABQ34343385-DF115DD8-6C14-42B7-BBBD-83347AE6B3F7Q34480747-CBD520D7-5A37-45D2-A2CA-711BBBD601ACQ34527664-4529ADD5-1566-483B-8567-77A2535CF729Q34607730-25B80EB4-91B8-4A46-9315-E462EBA85637Q34677347-471D7CAC-D762-44BA-88B2-3B752C686B7DQ34749450-5550586B-87EB-40AE-A78E-BA9CAA59001DQ34781733-7BF20888-B187-4E82-9BA4-05E9FCF42A2AQ34863566-679173BE-33EF-4D00-BC53-71B496B20242Q35090046-2C82F92A-9A28-425C-9510-790BD84CF629Q35630386-9FBFD02D-364F-4FB9-AE81-6DB8CC0AC631Q35880015-6A7BE198-DA98-4585-8836-A000676E4057Q35922947-75DA2F3B-5620-4AF4-A1B9-F52DD836FA5AQ35942924-5B538672-FC1B-4256-A9E0-94A786C8C52CQ36109106-64740131-AD24-4EFE-9DC1-FC32F6EEB609Q36216440-BE8F475D-3684-4EEF-ADC1-F6D8F1F5844EQ36407025-7FD159A4-2B84-4BDE-8AFB-9375C83D3455Q36448508-7F1D0765-518B-46B9-AED8-B90FEC9DA602
P50
name
Burkert Pieske
@en
Burkert Pieske
@nl
type
label
Burkert Pieske
@en
Burkert Pieske
@nl
prefLabel
Burkert Pieske
@en
Burkert Pieske
@nl